We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
No events to show.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
Nexentis Technologies (NXTS) Earnings Date and Reports 2026 - MarketBeat
Nexentis Technologies (NXTS) Earnings Date and Reports 2026 MarketBeat
Nexentis Technologies (NXTS) Surges 5.1%: Key Levels and Volume Patterns Signal Potential Breakout - Calendar Spread Trade - The Legal Advocate
Nexentis Technologies (NXTS) Surges 5.1%: Key Levels and Volume Patterns Signal Potential Breakout - Calendar Spread Trade The Legal Advocate
Nexentis Technologies (NXTS) Surges 5.1%: Key Levels and Volume Patterns Signal Potential Breakout - Cup and Handle - The Legal Advocate
Nexentis Technologies (NXTS) Surges 5.1%: Key Levels and Volume Patterns Signal Potential Breakout - Cup and Handle The Legal Advocate
Nexentis Technologies Inc. Approves Amendment to A Facility Agreement - marketscreener.com
Nexentis Technologies Inc. Approves Amendment to A Facility Agreement marketscreener.com
Nexentis Technologies (NASDAQ: NXTS) expands EUR 10M credit line and warrant terms - Stock Titan
Nexentis Technologies (NASDAQ: NXTS) expands EUR 10M credit line and warrant terms Stock Titan
Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-8.23 | — | — | $69K | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.54 | — | — | $61K | Reported |
| FY2025 Q1 | 2024. 03. 31. | Time TBD | — | $-0.26 | — | — | $44K | Reported |
| FY2024 Q3 | 2023. 09. 30. | Time TBD | — | $-4.69 | — | — | $157.62K | Reported |
No research actions to show.
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.